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We describe the construction of a panel data set from the U.S. patent data that contains measures of
inventors' life-cycle R&D productivity--patents and patent citations. We match the data set to information
on the U.S. pharmaceutical and semiconductor firms for whom they work. In this paper we use these
data to examine the role of research personnel as a pathway for the diffusion of ideas from foreign
countries to U.S. innovators. In particular, we find in recent years an increase in the extent that U.S.
innovating firms collaborate with or employ researchers with foreign experience. This increase appears
to work primarily through an increase in U.S. firms' employment of foreign-residing researchers; the
fraction of research-active U.S. residents with foreign research experience appears to be falling, suggesting
that U.S. pharmaceutical and semiconductor firms are increasingly locating operations in foreign countries
to employ such researchers, as opposed to such researchers immigrating to the U.S. to work. In addition,
we investigate which U.S. firms conducting R&D build upon innovations originating abroad. We find
that employing or collaborating with researchers who have research experience abroad seems to facilitate
the use of  output of non-U.S. R&D. We also find that in the semiconductor industry smaller and older
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1. Introduction 
Understanding the nature of knowledge spillovers is an important area of research 
because of its implications for economic growth and science and technology policy.  The 
importance of knowledge spillovers has been well recognized in the literature (for example, 
Griliches, 1992).  Knowledge spillovers can take place in a number of ways: through various 
methods of communication (scholarly publications, the material published in universities’ patent 
applications and the like) or through person-to-person contacts in informal settings.
1  Knowledge 
spillovers may also occur through employing or collaborating with researchers.  
Studies in both the economics and sociology of innovation literatures argue that new 
technologies are frequently difficult to transmit to the uninitiated via spoken or written 
communication (see Polyani, 1958, for an early discussion of the ‘tacitness’ of knowledge).   
Often the most efficient means of transmission across organizational boundaries for tacit 
knowledge is via person-to-person contact involving a transfer or exchange of personnel.  Recent 
findings that technological diffusion appears to be geographically limited (e.g., Jaffe, 1989; Jaffe, 
Trajtenberg, and Henderson, 1993; Audretsch and Feldman, 1996; Zucker, Darby, and Brewer, 
1998; and Mowery and Ziedonis, 2001) are often interpreted as evidence of the tacitness of 
knowledge.  Feldman (1994) suggests that tacit knowledge transmission can only take place 
through intense communication and is facilitated by close location.  
More direct evidence exists that person-to-person interaction is important for the 
diffusion of technology.  Cohen, Nelson, and Walsh (2002) surveyed R&D managers on the 
means by which they gather and assimilate new technologies.  They find that firms access 
                                                 
1  See Cohen, Nelson and Walsh (2002) on the various means by which innovating firms access know-how 
developed externally.  See Agrawal, Cockburn, and McHale (2003) for evidence of the importance of social 
networks in promoting diffusion.  Von Hippel (1988) documents how direct informal contacts between researchers 
affect knowledge spillovers.   2   
externally-located technology partly through the hiring of and collaboration with researchers 
from the outside.  Moreover, they find that hiring/collaboration with outside scientists is 
complementary to other means of accessing externally produced knowledge, such as through 
informal communications with outsiders and more formal (such as consulting) relationships with 
outsiders.  Almeida and Kogut (1999) find that scientific references that firms cite in their patent 
applications reflect the employment histories of their inventors, suggesting that ideas in the 
semiconductor industry are spread by the movement of key engineers among firms, especially 
within a geographical area.
2  Zucker, Darby, and Armstrong (2001) find evidence of a pay-off to 
firms that seek interactions with outside researchers.  They find a positive impact on patent 
productivity for biotech firms that collaborate with university researchers on research and 
scholarly publications. 
We have constructed a scientist-based data set that will allow us to study the role of 
research personnel as a pathway for the diffusion of ideas, among other aspects of innovation.  
This paper details the construction of these data and then describes their use in an analysis of the 
influence of foreign R&D on U.S. innovating firms.  This paper is part of a larger project 
examining empirically issues related to the labor market for scientists. 
The first half of the paper describes the construction of these data.  The inventors behind 
the patented invention, as well as their home addresses, are listed on each U.S. patent, as are the 
firms to which the patent is assigned and the assignees’ nationalities of incorporation.  The firm 
to which the patent is assigned is in most cases the employer of the persons named in the 
                                                 
2 See also the (indirect) evidence of a link between scientific mobility and technological diffusion in Kim and 
Marschke (2005) and Moen (2005).  Kim and Marschke find that firms are more likely to patent in environments 
where scientists are more likely to switch employers, suggesting that workers do transmit technological know-how 
when they move from one employer to another.  Technical knowledge acquired by the scientist that can be 
transmitted to future employers is a form of general human capital.  Thus, like general human capital, scientists 
should pay to acquire technological knowledge that they can exploit possibly with multiple employers with lower 
wages.  Moen finds some evidence of this: he shows that technical workers in R&D intensive firms in Norway 
accept lower wages early in their career in exchange for higher wages later.   3   
inventor field.  We match names in the inventor fields of patents to construct a panel data set of 
inventors that contains the patents in each year of the inventors’ careers.  The resulting data set 
allows us to track scientists geographically over the course of their career.  These data afford us a 
window on the migration of technological human capital across national borders, one possible 
mechanism by which technology diffuses internationally.  Patent applications disclose any 
knowledge they have of previous relevant inventions.  Through its citations to previous patents 
each patent documents the “prior art” upon which the new innovation builds, and because we 
know each cited patent’s assignee type, we know in which sector and country the prior art 
originated.  These citations provide an additional window on the pathways of knowledge.  In the 
final stage of constructing our patent-inventor data set we merge in citations made by the patent 
for each patent to which the inventor is named.  
One use to which we wish to put our data is in understanding the factors that influence 
the innovating firm’s accessing of recent innovations developed externally.  A focus of this part 
of the analysis is the pharmaceutical and semiconductor industries, two industries that are 
especially prolific generators of innovations and patents.  Thus the last stage of data construction 
involves carefully matching the inventor data to data on publicly traded firms in these two 
industries. 
After detailing our data construction efforts, we put our data to use investigating the 
international transmission of technology through scientific labor markets.  For each patent 
assigned to a U.S. firm, we can determine the country of the inventor’s residence at the time of 
patent application, and whether they had ever been named as an inventor on a patent while 
residing abroad.  Inventing in a foreign country can be regarded as evidence of an inventor’s   4   
exposure to research abroad.  We also investigate which U.S. firms in our two industries cite 
foreign-assigned patents as prior art and thus build upon innovations originating abroad. 
Our main findings are the following.  We find that there has been an increase in recent 
years of U.S. innovating firms employing or collaborating with researchers with foreign 
experience.  This increase appears to work primarily through an increase in U.S. firms’ 
employment of foreign-residing researchers; the fraction of research-active U.S. residents with 
foreign research experience appears to be falling, suggesting that U.S. pharmaceutical and 
semiconductor firms are going to foreign countries to employ such researchers as opposed to 
such researchers immigrating to the U.S. to work for U.S. firms.  In addition we investigate the 
firm-level determinants of accessing non-U.S. technological know-how.  We find, for example, 
that employing or collaborating with researchers with research experience abroad seems to 
facilitate this access.  Also, in the semiconductor industry, smaller and older firms and in the 
pharmaceutical industry, younger firms are more likely to make use of the output of non-U.S. 
R&D. 
The paper is organized as follows.  Sections 2 and 3 describe the sources for the data 
construction and the construction itself.  Section 4 details some descriptive statistics of the data 
set.  Section 5 describes our analysis on the influence of foreign R&D on U.S. innovation.   
Section 6 concludes. 
 
2. Data Sources 
The data set we have created contains measures—patents and patent citations—of the 
R&D productivity of individual researchers between 1975 and 1998 and includes information on 
their advanced degrees in the natural sciences and engineering fields.  These data also contain, 
for patents assigned to publicly traded firms in the U.S. pharmaceutical (Primary SIC code 2834)   5   
or semiconductor industry (Primary SIC code 3674), information (e.g., firm size and R&D 
expenditures) on the patents’ assignees.  Budgetary and time constraints limited the number of 
industries that we could include in our analysis.  The pharmaceutical and semiconductor 
industries were selected because they are especially prolific generators of innovations
3 and their 
products are relatively homogeneous
4 compared to those of other industries. 
The data for this study come from six sources: (1) Patent Bibliographic data (Patents 
BIB) released by the U.S. Patent and Trademark Office (U.S.PTO), which contains bibliographic 
information on all U.S. utility patents issued from 1969 to 2002; (2) the ProQuest Digital 
Dissertation Abstracts database, which contains information on the date, field, and type of degree 
for those who earned degrees in all natural science and engineering fields between 1945-2003; 
(3) the Compact D/SEC database from 1989 to 1997, which contains firm information taken 
primarily from 10-K reports filed with the Securities and Exchange Commission; (4) the 
Standard & Poor’s Annual Guide to Stocks-Directory of Obsolete Securities, which includes a 
history of firm name changes, and merger and acquisition; (5) the Thomas Register, Mergent, 
and Corptech data which report a firm’s founding year, and finally (6) the NBER Patent-
Citations data collected by Hall, Jaffe and Trajtenberg (2001), which contain all citations made 
by patents granted in 1975-1999.  These data sources are described in detail below and variables 
used in our study from each data source are in Table 1. 
 
2.1.  Patent Bibliographic data (Patents BIB) 
                                                 
3 Based on NBER-Case Western University data of U.S. patents from 1963 to 1999, 15.3% of industry patents were 
granted to the firms in the pharmaceutical industry and 14.8% were granted to those in the semiconductor industry. 
4 In a cross-sectional analysis involving multiple industries, differing technologies and patent propensities make 
interpretation of results difficult.  By limiting analysis to the patents and their inventors in a specific industry, we 
resolve heterogeneity in the propensity to patent across industries, thus making comparisons of patents and citations 
more meaningful.   6   
  Patents BIB is one of the Cassis Series of optical disc products released by the U.S.PTO.  
Patents BIB contains bibliographic information for U.S. utility patents issued since January 1969.  
The information includes patent ID number, dates of the patent’s application and granting, patent 
assignee, and geographic information on all inventors involved.  The original optical disc we use 
covers patents issued between 1969 and 2002, and contains over 3 million U.S. patents granted.  
We use only the patents granted after January 1975 because detailed geographic information for 
all inventors is available in Patents BIB only for patents granted after that date.  Most foreign 
innovating firms, especially those in Western Europe and in Japan apply for patents in the U.S. 
in addition to their home countries so that U.S. patent data reflect nearly the universe of patented 
innovations. The number of patents during this period is 2,493,610 (U.S. Patent No. 3,858,241 
through 6,351,850), which together list 5,105,754 inventors (an average of 2.05 inventors listed 
per patent).   
 
2.2.  ProQuest Digital Dissertation Abstracts 
  This database contains information on the author and the title of dissertation, degree 
conferring institution, date of degree, academic field, and type of degree (MA, MS, MBA, LLM, 
Ph.D., or Ph.D. equivalent) for those who earned degrees between 1945 and 2003 from over 
1,000 North American graduate schools and European universities.  Before matching to Patent 
BIB information of inventors, we took total 1,068,551 dissertation abstracts in all the natural 
science and engineering fields among over 2 million doctoral dissertations and Masters theses in 
all fields of the ProQuest database.  
   7   
2.3.  Compact D/SEC  
  The Compact D/SEC contains about 12,000 firms that have at least $5 million in assets 
and at least 500 shareholders of one class of stock of U.S. companies traded on the American 
Stock Exchange, the NASDAQ, the New York Stock Exchange, or the Over-the-Counter 
equities market.  The data set provides financial and other information obtained from Annual 
Reports, 10-K and 20-F filings, and Proxy Statements for those companies.  Most of the 
companies included are American.  Company records include directory information, primary and 
secondary SIC codes, brief business descriptions, names of subsidiaries, names of top executives, 
ownership data, financial data, and excerpts from annual reports and other SEC reports.  
 
2.4.  Standard & Poor’s Annual Guide to Stocks  (S&P) 
  The firm-level information from the Compact D/SEC data cannot be directly matched to 
assignees in the Patents BIB data because parent firms patent sometimes under their own names 
and other times under the names of their subsidiaries.  Mergers and acquisitions at both the 
parent firm and subsidiary levels and name changes further complicate linking the patent to firm-
level data.  To track the ownership of firms over the entire period of our study, we use the 
information in the Standard & Poor’s Annual Guide to Stocks.  The S&P data provide histories 
of firm ownership changes due to mergers and acquisitions, bankruptcy, dissolution, and name 
changes, updated through December 2002.   
 
2.5.  NBER Patent-Citations 
  Patent applicants are legally obligated to disclose any knowledge they have of previous 
relevant inventions.  Citations are of two kinds: to science (or prior science publications) and to   8   
technology (or previous patents).  The patent examiner may add to the application relevant 
citations omitted by the applicant.  Thus, through the patent citations each patent documents the 
“prior art” upon which the new innovation builds.  Through the citations we can trace knowledge 
flow, measure the “closeness” of technological innovations, and measure an innovation’s impact.   
  The data collected by Hall, Jaffe and Trajtenberg (2001) contain all citations made and 
received by patents granted between 1975 and 1999.  Their data contain a total of 16,522,438 
citation records; the mean number of citations received by a patent is 5.07, ranging from a 
minimum of 1 and a maximum of 779, respectively.  The number of patents granted to the firms 
identified in the pharmaceutical and semiconductor industries between 1975 and 1999 is 244,158.  
The mean citations received by a patent in these two industries is 8.13, ranging from a minimum 
of 1 and a maximum of 631. 
 
3. Data Set Construction Process 
This section discusses key issues that arise in assembling our data set from these six 
sources.  The assembly requires three steps.  First, we create an inventor identifier in Patents BIB 
because of the non-uniqueness of inventors’ names.  The primary challenge in this step is 
identifying who is who among inventors with same or similar names.  The authors in the 
Dissertation Abstract data are then matched with inventors in the Patents BIB data.  Second, we 
identify each firm’s ownership structure of subsidiaries and their name changes over the data 
period to construct firm-level data, using the Compact D/SEC and the S&P data.  In the final step, 
we combine the inventor data and the firm data and then add the patent citation data where each 
citing patent that was granted between 1975 and 1999 is matched to all patents cited by the 
patent.     9   
 
3.1.  Identifying the same inventor among ‘same/similar’ names 
Over 5.1 million inventor names are contained in the U.S. patent data from January 1975 
through February 2002.  Each inventor name record includes the last name, first name, middle 
name and suffix (Jr., Sr., etc.) of the inventor, as well as his/her street address, city, state, zip 
code (often missing), and country of residence at the time of the granting of the patent.  
Identifying the same inventor in different records with same or similar names (for 
example, John Maynard Keynes, John M. Keynes, John Keynes and John Keyens) is not an easy 
task.  Our matching method uses as much information in the patent data as possible to increase 
the number of names matches without losing matching accuracy.  Our name-matching 
methodology is similar to that in Trajtenberg (2004).   
To start, we treat each entry that appears in the inventor name field of every patent in the 
Patents BIB data as a unique inventor.  Given N number of names in this name pool, we pair 
each name with all other names, which generates N(N-1)/2 number of unique pairs.  The 5.1 
million names in the Patents BIB data (2.05 inventors per patent) thus produce 13 trillion unique 
pairs.  For each pair, we consider the two names as belonging to the same inventor if the 
SOUNDEX codes of their last names and their full first names are the same, and at least one of 
the following three conditions is met: (1) the full addresses for the pair of names are the same; 
(2) one name from the pair is an inventor of a patent that is cited by another patent whose 
inventors include the other name from the pair; or (3) the two names from the pair share the same 
co-inventor.  These three criteria in our name matching method are similar to the “Strong” 
criteria of Trajtenberg (2004).     10    
SOUNDEX is a coded index for last names based on the way a last name sounds in 
English rather than the way it is spelled.  Last names that sound the same, but are spelled 
differently, like SMITH and SMYTH, have the same SOUNDEX code.  We use the SOUNDEX 
coding method to expand the list of similar last names to overcome the potential for misspellings 
and inconsistent foreign name translations to English; misspellings are common in the U.S.PTO 
data as are names of non-Western European origin (see Appendix A for the detailed SOUNDEX 
coding method).   
We also consider a pair of names as a match if two have the same full last and first names, 
and at least one of the following two conditions is met: (1) the two have the same zip code; or (2) 
they have the same full middle name.  These two criteria correspond to the “Medium” criteria of 
Trajtenberg (2004).  As an additional step beyond the aforementioned pair-wise comparisons, we 
treat a pair of inventors as mismatched if the middle name initials of the pair are different. 
Table 2 illustrates our name-matching procedure.  Inventors 001 and 002 in Table 2 have 
the same last and first names, and share the same co-inventor.  Thus, the two records in this pair 
are treated as the same inventor.  Inventors 002 and 003 do not have the same full middle name 
but share the same zip code, and thus the two inventors are treated as the same inventor.   
Although inventors 002 and 005 share the same zip code, the middle name initials are different.  
Therefore, the pair is not considered a match (they would not be considered a match by our 
algorithm even if their street addresses were identical, possibly a case of a parent and a child).  
 
Imposing transitivity 
Transitivity is imposed in the following sense: If name A is matched to name B and name 
B is matched to name C, name A is then matched to name C.  We iterate this process until all 
possible transitivity matches are completed.  After the transitivity procedure, we assign the same   11    
inventor ID number for all the names matched.  For instance, inventors 001 and 003 are not 
linked in the initial round of name matching, but they are matched through transitivity because 
inventors 001 and 002 are matched and inventors 002 and 003 are matched.   
Imposing transitivity, however, poses a possibility of name mismatch.  Suppose, for 
example, Adam E. Smith and Adam Smith are matched in one pair, and Adam J. Smith and the 
same Adam Smith are matched in another pair.  According to our transitivity procedure, Adam E. 
Smith and Adam J. Smith are identified as a match although their middle name initials are 
different.  The number of matches through transitivity suffering from this problem appears to be 
trivial, however: we find 126 cases where two inventors are matched although their middle 
names were different out of 2.3 million uniquely identified inventors.  Upon further investigation 
of these cases, we found the mismatches are of three kinds.  In the first kind, some middle names 
in the Patents BIB data are incorrectly coded.  For instance, our transitivity procedure matched 
the names ‘Laszlo Andra Szporny’ and ‘Laszlo Eszter Szporny’ which appear to belong to the 
same inventor according to other information.  We found that this particular inventor does not 
have a middle name, and the middle names attributed to him were in fact the first names of the 
next co-inventors listed on his patents.  In the second kind of mismatch, an inventor with two 
middle names is coded in the Patents BIB data with one middle name in some cases and with the 
other middle name in other cases.  In the third kind, a mismatch occurs when two inventors with 
the same last and first name but different middle names appear in the same patent.  We corrected 
by hand instances of the first two kinds of mismatch, but dropped from our data the observations 
displaying the third kind of mismatch.  
Trajtenberg (2004) assigns scores for each matching criterion and considers a pair 
matched only if its total score from all matching criteria exceeds a threshold.  Because the choice   12    
of weights and the score threshold for a match is largely arbitrary, we do not use this scoring 
method in our data construction.  Our method also differs in that we do not use as a matching 
criterion whether two inventors share the same assignee because name matching based on this 
criterion might bias our measure of mobility among inventors.  Instead we apply the rule that two 
inventors are not treated as a match if their middle name initials differ.  From our experience 
with the patent data, imposing this rule is effective because the SOUNDEX coding system 
sometimes so loosely specifies names that apparently different last names are considered a match.   
In the end, because of these differences, the number of distinct inventors identified with 
our procedure is a little higher than the number of distinct inventors reported in Trajtenberg 
(2004).  We identified 2.3 million unique inventors (45%) out of 5.1 million names in the entire 
patent data while Trajtenberg (2004) found 1.6 million distinctive inventors (37%) out of 4.3 
million names.  Note that our patent database is larger because it includes additional years, 2000-
2002.  
 
Adding in Dissertation Abstracts information 
We next match names in the Dissertation Abstract data to the inventors in the patent data.  
Each inventor identified through the above-described procedure may have a list of names 
matched to him or her (for example, John Maynard Keynes, John M. Keynes, John Keynes) due 
to names linked to each other by employing our matching criteria.  Since the Dissertation 
Abstract data contain for each individual a full name in a string instead of separate last, first and 
middle name fields, we convert all the names under each inventor ID number in the patent data   13    
to strings to search for them within the Dissertation Abstract data.
6  When an inventor holds 
multiple degrees, we assign the highest degree to the inventor.  On rare occasions when multiple 
names from the Dissertation Abstract data are matched to one ID number in the patent data, we 
randomly pick one name.  Out of 2.3 million unique inventors in our patent data, 5.3 percent 
(122,168) are identified as holders of advanced degrees. 
 
3.2.  Identifying the ownership structure and combining patent-inventor data with firm data  
Because parent firms patent sometimes under their own names and at other times under 
the names of their subsidiaries, combining the Patents BIB data with firm-level data in the 
Compact D/SEC data is not straightforward.  Mergers and acquisitions at both the parent firm 
and subsidiary levels, common in these two industries during the 1990s, and name changes 
complicate linking the patent to firm-level data.  (The U.S.PTO does not maintain a unique 
identifier for each patenting assignee at the parent firm level nor does it track assignee name 
changes.)  Thus, to use the firm-level information available in the Compact D/SEC data, the 
names of parent firms and their subsidiaries and the ownership of firms must be tracked over the 
entire period of the study.
7 
To start, we identify mergers and acquisitions, and name changes of firms in the two 
industries, pharmaceutical preparation (primary SIC code 2834) and semiconductor and related 
devices (3674), over the period between 1989 and 1997, using the Standard & Poor’s data.  We 
also identify the ownership structure of subsidiaries of firms using subsidiaries information 
                                                 
6 In addition, we impose conditions on the time frame of the inventor’s patenting history as follows: the inventor’s 
last patent is no later than forty years following the dissertation date, and the first patent is no more than twenty 
years before the dissertation date. 
7  NBER-CWRU researchers created a database of parent firms and their subsidiaries for all the names among 
U.S.PTO patent assignees.  However, they only linked subsidiaries based on the corporate ownership structure as it 
existed in 1989.   14    
available from the Compact D/SEC from 1989 to 1997.
8  We can then relate each assignee in the 
patent data to a firm in the Compact D/SEC data, which enables us to match each patent to a firm 
in the Compact D/SEC data.  We then combine firms’ founding years, obtained from Thomas 
Register, Mergent, and Corptech, with the other firm-level information. 
As the final step, we add information on all citations from the NBER Patent-Citations 
data collected by Hall, Jaffe and Trajtenberg (2001) where each citing patent that was granted 
between 1975 and 1999 is matched to all patents cited by the patent. 
 
4. Descriptive statistics 
Figure 1 provides a distribution of U.S. patents granted by year of application.  The 
annual number of patents granted dips sharply after 1997.  This dip reflects a lag between the 
application and granting dates.  About 70 to 80 percent of all patent applications ultimately 
granted are granted within the first three years of the application and 97 percent of all patent 
applications are granted within the first four years of the application date (Hall, Griliches, and 
Hausman, 1986). Between January 1975 and February 2002, 45.5% were granted to the U.S. 
assignees and 37.4% were granted to foreign assignees (see Table 3).  In Figure 2, we report the 
number of patents granted to firms in each of our two industries.  Note that in both industries the 
number of patents granted annually rose over the period we study: the annual number of patents 
granted between 1989 and 1998 rose from about one thousand patents annually, but by a factor 
of two in the pharmaceutical industry and nearly seven in the semiconductor industry. 
Table 4 shows that the number of inventors named as an inventor to at least one patent 
assigned to a firm in one of our two industries is 59,292 out of the 2,299,579 unique inventors in 
                                                 
8 The subsidiary list reported in the Compact D/SEC is not always complete. For example, some subsidiaries appear 
intermittently and some firms report subsidiaries every other year. Hence, we have treated a subsidiary as one for the 
firm throughout the period 1989-1997, if it is reported once as a subsidiary of the firm.   15    
our data (25,609 inventors in the pharmaceutical and 33,683 in the semiconductor industry).  The 
percentage of master’s or higher-degree holders in natural science and engineering is relatively 
higher in these two industries.  Among the 2,299,579 unique inventors in our data, 5.3% hold 
masters or higher degrees (3% of inventors hold a Ph.D. or equivalent).  Among the inventors in 
the pharmaceutical and semiconductor industries, 13.3% and 11.7%, respectively, hold an 
advanced degree.  
Inventors working in these pharmaceutical and semiconductor industries are named as 
inventors on more patents on average than inventors in other industries (see Table 4).  An 
inventor in a pharmaceutical firm is named as an inventor on average on 2.80 patents over our 
sample period, whereas an inventor in the semiconductor industry appears on average on 2.60 
patents.  Inventors with advanced degrees are shown in Table 4 to have more patents than those 
without advanced degrees.  While advanced-degree holders in the pharmaceutical industry are 
more productive in patent output, those in the semiconductor industry appear to be similar in 
patent productivity to advanced-degree holders in other industries. 
  We identified pharmaceutical and semiconductor firms in the Compact D/SEC data by 
their primary SIC. We identified 447 parent firms and 5,331 subsidiary firms in the 
pharmaceutical industry and 332 parent firms and 4,211 subsidiary firms in the semiconductor 
industry.  Firm information period is from 1989 because we had access to only the Compact 
D/SEC data beginning in 1989.  We then dropped all patent applications filed after 1997 because 
we found that starting with application year 1998 the patent time series tailed off due to the 
review lag at the U.S.PTO. 
Some sample statistics from the firms in the two industries in our data—the number of 
selected firms and the number of employees, sales, and R&D expenditures—are reported in   16    
Table 5.  For the year 1997, for example, the data show 221 firms in the pharmaceutical and 151 
firms in the semiconductor industry, with 177 firms and 135 firms, respectively, reporting 
positive R&D expenditures.  Pharmaceutical industry firms are larger in terms of number of 
employees, sales volume, and R&D expenditures.   
 
5. International Knowledge Flow 
In this section, we test if the international migration of researchers facilitates knowledge 
transfers across borders.  Understanding the consequences of the immigration of scientists and 
researchers to the U.S.—on not only for U.S. R&D productivity but for the wages and job 
prospects of native workers and for national security—has important implications for policy-
making in the immigration, labor market, and education arenas.  Understanding how knowledge 
spillovers across countries work is of interest because of the role spillovers may play in 
economic growth and because of its implications for science and technology policy.  Knowledge 
spillovers from the U.S. and Europe may be an important factor for the impressive growth rates 
enjoyed in countries such as South Korea and Taiwan (Hu and Jaffe, 2003).  As described in this 
paper’s introduction, work done with patent citations suggests that knowledge flows may be 
geographically localized (Jaffe, Trajtenberg, and Henderson, 1993).  Some researchers have used 
patent citations to try to understand these international knowledge spillovers (Jaffe and 
Trajtenberg, 1998).  We use the geographic mobility of scientists to track the transmission of 
foreign knowledge from other countries to the U.S. and to obtain a better estimate of the 
importance of international scientific labor markets as a mechanism of technological 
transmission than has been possible previously.   17    
Table 6 shows the annual number of unique inventors named on U.S. domestic patents 
for the years 1985 through 1997.  It also shows the percentage of inventors who (1) at the time of 
the patent application resided in a foreign country, (2) at the time of the patent application 
resided in the U.S. and had been previously listed as a foreign-residing inventor on a successful 
patent application, and (3) at the time of the patent application resided in the U.S. but had never 
been previously listed as a foreign residing inventor on a successful patent application.  Because 
our data included patents granted in 1975 and later, we imposed a cut-off for the patents used to 
define whether an inventor has foreign-experience at the time of the patent’s application.  We 
chose to consider only those inventors who are currently foreign residents or had been foreign 
residents some time in the ten-year period prior to the date of the patent’s application because ten 
years still leaves us a long period over which to conduct our analysis and because knowledge 
acquired in a foreign country far in the past may not be very valuable. 
Table 6 shows a steady and swift increase in the number of unique inventors on U.S. 
domestic patents between 1985 and 1997, from 42,368 to 119,556, which translates to an average 
annual growth rate of 9 percent.  Among those inventors with foreign experience, the percentage 
of inventors with current foreign addresses increased steadily during the period from 8.15 
percent to 9.11 percent while the percentage of U.S.-residing inventors with foreign experience 
increased from 0.99 percent in 1985 to 1.30 percent in 1992, then dropping to 1.01 percent in 
1997.  Overall, the percentage of inventors with foreign experience increased (from 9.14 percent 
in 1985 to 10.13 percent in 1997). 
Table 6 shows that the growth in the number of inventors in the pharmaceutical (13 
percent annually) and semiconductor (31 percent annually) industries has been significantly 
faster than for all industries combined. In the pharmaceutical industry the share of inventors with   18    
foreign experience grew rapidly although the increase is mostly in the share of inventors with 
current foreign addresses and there is a decrease in the fraction of U.S.-residing inventors with 
past foreign experience.  This finding is not surprising given the increasing rate at which U.S. 
pharmaceutical firms have been citing new laboratories abroad (Chacar and Lieberman, 2003) 
and findings that collaborations among academic scientists have become more dispersed, 
possibly due to improvements in telecommunications (Adams, Black, Clemmons, and Stephan, 
2004).  The semiconductor industry shows a similar pattern, but the changes are less pronounced 
than in pharmaceutical industry.  
Figure 3A shows the average patent productivity of inventors in U.S. domestic patents by 
foreign-experience type for all patents.  We first note that U.S.-residing inventors with past 
foreign experience have significantly higher patent-inventor ratio than other types of inventors.  
There are at least two reasons for this.  First, inventors with higher productivity are more likely 
to migrate to the U.S. because of better compensation in the U.S. labor market or because of U.S. 
immigration policies.  Alternatively, foreign experience somehow improves the productivity of 
researchers.  Both the patent-inventor ratios for current foreign residents and for current U.S. 
residents without foreign experience show a similar level.  Figure 3A also shows that the patent 
productivity for inventors with past foreign experience was steady at around 1.6 patents per 
inventor until 1993 and then it rose to 2 patents per inventor in 1997.  On the other hand, the 
patent-inventor ratios for other types of inventors were stable or declined slightly over the period.   
Figures 3B and 3C repeat the analysis of Figure 3A but for the pharmaceutical and 
semiconductor industries alone.  These figures show the same gap between the productivity of 
U.S.-residing inventors with foreign experience and the U.S.-residing inventors without foreign   19    
experience and the foreign- residing inventors.  These figures also show the productivity of U.S.-
residing inventors with foreign experience increasing over the 1990s. 
Where Figures 3A-C tracks the productivity of inventors by their patent output, Figures 
4A-C tracks how the quality of inventors’ output changes by inventor type.  Figure 4A shows the 
citations received in the 5-year period after application filing per patent by inventor type for all 
industries over time.  This figure covers only years of application up to 1992 because the NBER 
citation data contain citations made by patents granted in years up to 1999 and we take into 
account the 5-year period of citation and a 2-year gap between application and granting dates.  
Between 1985 and 1992, the citations per patent rose for all three classes of inventors.   
Throughout the 1985-1992 period, the average citations per patent produced was the highest for 
U.S. residents with foreign experience and lowest for foreign residing inventors.  In 1992, the 
number of citations attracted by the average patent of a U.S. residing inventor with foreign-
patenting experience, of a U.S.-residing inventor without foreign patenting experience, and of a 
foreign residing inventor, was about 6.5, 5, and 3.5 respectively.  Thus, taken together, Figures 
3A and 4A show that U.S.-residing inventors with foreign experience produce more patents on 
average and patents of higher quality than the other two classes of inventors.  Figures 4B and 4C 
conduct the analysis separately for the pharmaceutical and semiconductor industries.  The 
semiconductor industry shows the same ordering of inventor types, though the levels are higher 
for each type.  The pharmaceutical industry however shows no clear distinction between the two 
classes of U.S.-residing inventors.  Figure 4C does show that foreign-residing inventors produce 
the lowest quality patents, by the citation measure. 
Is a patent more likely to cite foreign-assignee patents when its inventors have foreign 
experience?  We are interested in learning if knowledge spillovers from foreign countries are   20    
facilitated by direct exposure to inventors with foreign experience.  Table 8 presents the results 
of our estimation of the determinants of accessing foreign knowledge in two industries: 
pharmaceutical and semiconductor industry.  The unit of observation of the regression is a patent 
applied for in year 1997.  The dependent variable is the logit transformation of the fraction of 
citations to patents that are assigned to foreign assignees (CITE_FRGN).  The key regressor in 
these regressions is a binary variable which takes 1 if at least one inventor on the patent is 
currently residing or formerly resided in one of the foreign countries where foreign assignees of 
cited patents are located (FRGN_EXP).  Note that this regressor reflects not just whether an 
inventor has foreign experience but which country the inventor has experience from.  We 
speculate that knowledge spillover is country-specific.   
The regressions in Table 8 also include as right-hand side variables firm-level 
characteristics in the year 1997.  A measure of the size of the research operation, proxied by the 
number of unique inventors named to patents awarded to the firm in 1997 (INVENTOR), is 
included to examine whether large-scale R&D enterprises are more likely to rely on foreign 
knowledge.  We use the number of employees (EMPLOYEE) as an alternative measure of 
organizational size at the firm level.  Included are the R&D-inventor ratio (R&D/INV) and the 
number of business lines in the firm (NSIC), measured by the number of secondary SIC’s 
identified with the firm.  We include the R&D-inventor ratio (R&D/INV) as a regressor because 
a highly capitalized firm may rely on more advanced technology and thus may be more open to 
foreign technology.  We include NSIC as a regressor to estimate the impact of economies of 
scope in the firm’s use of foreign knowledge.  Our regressions also include two additional 
regressors: the median experience of all inventors in the firm (MEXP) and years elapsed since   21    
the founding year of the firm (FIRMAGE).  The means and standard deviations of the 
independent and dependent variables, along with their definitions, are described in Table 7.
9   
Column 1 in Table 8 for each industry panel shows the estimated relationship between 
the fraction of a patent’s citations to foreign-assigned patents and the existence of foreign-
experienced inventors using OLS.  Column 2 for each industry panel reports the estimates of the 
determinants of the citation to foreign patents.   
One concern for our regression is that inventors are more likely to cite their own past 
patents than other inventors’ patents, which may drive the estimated relationship between our 
dependent variable and the key regressor, FRGN_EXP.  In column 3 for each industry panel we 
thus exclude patents which have the same inventors as those in their cited patents.  
The results in Table 8 show that a patent by inventors with foreign experience in both 
industries is more likely to cite patents assigned to foreign firms from the same country where 
the inventors are residing or resided in the past: FRGN_EXP has a significantly positive effect in 
all models.  This effect is still significant with the data without self-citing patents.  
The results show a negative effect of the size of the R&D enterprise on the fraction of 
citations to foreign patents in the semiconductor industry.  There is no significant effect of the 
size of the R&D enterprise in the pharmaceutical industry.  On the other hand, the coefficient 
estimate on the firm size variable (EMPLOYEE) is insignificant in all models.  The coefficient 
estimate on logR&D/INV is generally positive but insignificant in all regressions.  The 
coefficient estimate on log NSIC is never significant by conventional criteria of significance.  
The coefficient estimate on log MEXP is negative and significant for both industries.  This may 
partly reflect that it is more costly for older inventors to learn new technologies from abroad, or 
                                                 
9 Note that the means of the variables reported in table 7 are not the averages across firms because our regressions 
are at the patent level, not at the firm level.  For instance, the mean value of INVENTOR and EMPLOYEE is 
greater than the firm mean in 1997 because larger firms tend to have more patents.   22    
it may be due to a vintage or a composition effect (e.g., areas of technology that experienced 
innovators innovate in are somehow more “domestic”).  The coefficient estimate on log 
FIRMAGE is significant for both industries but has different signs for the two industries.  The 
effect is negative in pharmaceutical industry while it is positive in semiconductor industry.  That 
is, we find that in the semiconductor industry older firms, and in the pharmaceutical industry, 
younger firms are more likely to make use of the output of non-U.S. R&D.   
 
6. Conclusion 
We describe the construction of a panel data set that links inventors to the U.S. 
pharmaceutical and semiconductor firms for whom they work.  These data contain measures of 
inventors’ R&D productivity—patents and patent citations—as well as information on the firms 
to which their patents are assigned.  In this paper we use these data to examine the role of 
research personnel as a pathway for the diffusion of ideas from foreign to U.S. innovators.  In 
particular, we find in recent years an increase in the extent that U.S. innovators employ or 
collaborate with researchers with foreign R&D experience.  This increase appears to work 
primarily through an increase in U.S. firms’ employment of foreign-residing researchers; the 
fraction of research-active U.S. residents with foreign research experience appears to be falling, 
suggesting that U.S. pharmaceutical and semiconductor firms are increasingly locating 
operations in foreign countries to employ such researchers, as opposed to such researchers 
immigrating to the U.S. to work.  In addition we investigate the firm-level determinants of 
accessing non-U.S. technological know-how, as measured by the prevalence of citations to 
patents on innovations originating outside the U.S.  We find that employing researchers who 
have research experience abroad seems to facilitate this access.  We also find that in the   23    
semiconductor industry smaller and older firms, and in the pharmaceutical industry, younger 
firms are more likely to make use of the output of non-U.S. R&D.  
We anticipate this data set will be useful in addressing other important questions.  These 
data will allow us to investigate the consequences of the mobility of R&D personnel on firm 
R&D.  What is the impact, for example, of the arrival of a researcher with a particular set of 
R&D experiences on the character and quantity R&D done by a firm?  We will be able to 
address this question because we know each scientist’s patenting history, both in terms of 
quantity but we also know the kinds of technologies underlying the innovations.  This data set 
will allow us to directly observe the importance of inter-firm mobility for technological diffusion.  
From the perspective of the scientist, this data set will allow us to examine the determinants of 
inter-firm mobility.  The panel nature of these data will allow us to investigate the productivity 
profiles of researchers working in industry over their careers.  Because we observe all the 
inventors responsible for a patent we will be able to use this data set to investigate how firms 
organize the R&D enterprise, the extent of collaboration among scientists who are 
geographically dispersed, and the extent of interaction among scientists with different 
backgrounds. 
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Appendix A.  The SOUNDEX Coding System 
 
The SOUNDEX is a coded index for last names based on the way a last name sounds 
rather than the way it is spelled.  Last names that sound the same, but are spelled differently, 
such as SMITH and SMYTH, have the same SOUNDEX code.  We use the SOUNDEX coding 
method to expand the list of similar last names to overcome the potential for misspellings and 
inconsistent foreign name translations into English; misspellings are common in the U.S.PTO 
data, as are names of non-Western European origin.  
A SOUNDEX code for a last name takes an upper case initial followed by 6-digit 
numeric codes.  For example, the SOUNDEX code for Keynes is K520000.  The rules for 
generating a SOUNDEX code are
10:  
1.  Take the first letter of the last name and capitalize it. 
2.  Go through each of the following letters giving them numerical values from 1 to 6 if they are 
found in the Scoring Letter table (1 for B, F, P, V; 2 for C, G, J, K, Q, S, X, Z; 3 for D, T; 4 
for L; 5 for M, N; 6 for R; 0 for Vowels, punctuation, H, W, Y).  
3.  Ignore any letter if it is not a scoring character. This means that all vowels as well as the 
letters h, y and w are ignored. 
4.  If the value of a scoring character is the same as the previous letter, ignore it. Thus, if two ‘t’s 
come together in the middle of a name they are treated as a single ‘t’ or a single ‘d’. If they 
are separated by another non-scoring character then the same score can follow in the final 
code. The name PETTIT is coded as P330000. The second ‘T’ is ignored but the third one is 
not, since a non-scoring ‘I’ intervenes.  
5.  Add the number onto the end of the SOUNDEX code if it is not to be ignored. 
6.  Keep working through the name until you have created a code of 6 characters maximum. 
7.  If you come to the end of the name before you reach 6 characters, pad out the end of the code 
with zeros. 
8.  You may choose to ignore a possessive prefix such as ‘Von’ or ‘Des’. 
See "Using the Census SOUNDEX," General Information Leaflet 55 (Washington, DC: 
National Archives and Records Administration, 1995) for the detailed method. 
 
                                                 
10 The strings of ‘-, ., +, /, (, ), %, ?, #, &, ", _’ in all name fields have been translated to blank space in advance and 
then last names are SOUNDEX coded.   25    
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Figure 3.  Patent-Inventor Ratio by Foreign-Experience type 



















































































Current foreign residents Current US residents w/ foreign experience
Current US residents w/o foreign experience
 


































































































































r  29    
Figure 4.  Citations per Patent by Foreign-Experience type 
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Table 1.  Variables from Each Data Source 
 
Data Source  Variables 
Patents BIB  Patent ID number, application year, inventors’ names, address, city, 
state, country, assignee ID and assignee name 
ProQuest  Degree holders’ name, institution, degree type, degree year, and field 
Compact D/SEC  Firm name, primary and other corresponding SIC codes, R&D 
expenditures, sales, number of employee, capital, and subsidiaries of 
the firms 
S&P  Firm name and ownership changes due from merger and acquisition, 
and obsolete securities due to bankruptcy or dissolution 
Thomas 
Register 
Founding year of firm 
Citation  Citing patent number and cited patent number 
   31    
Table 2.  Examples of Name Matching 
 
Initial ID  Inventor name  Co-inventor  Middle name  ZIP  Final ID 
001  Adam Smith   John Keynes    20012  001 
002  Adam Smith   John Keynes  Emmanuel  14228  001 
003 Adam  Smith    E  14228  001 
004 Adam  Smith     Emmanuel  14214  001 
005  Adam Smith   John Keynes  J  14228  005 
006  Adam Smyth   John Keynes    14228  001 
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Table 3.  Number of Patents by Assignee Type (January 1975 − February 2002) 
 
Assignee Description #  Observations  Percentage 
  Assigned to U.S. organization and 
state/local governments 
1,090,194 43.7 
US  Assigned to a U.S. resident (individual)  15,849 0.6  45.5
  Assigned to a U.S. Federal Government 
organization 
30,431 1.2 
  Assigned to a non-U.S., non-
government organization 
914,826 36.7 
Foreign  Assigned to a non-U.S. resident 
(individual) 
7,873 0.3 37.4
  Assigned to a non-U.S. government 
organization (all levels) 
8,613 0.4 
Unassigned 412,621 16.6 
Others 
Missing observations   13,203 0.5 
17.1
Total   2,493,610   
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Table 4.  Patent Statistics for All Inventors and for Inventors with Advanced Degrees  
(January 1975 − February 2002) 
   
 Total  Pharmaceutical  Semiconductor 
Inventors (a)  2,299,579  25,609  33,683 
No. of Patent per Inventor  2.22 2.80 2.60 
Degree holders* (b)  122,168  3,399  3,941 
No. of Patent per Inventor  3.07 3.70 2.95 
(b/a) 5.3%  13.3%  11.7% 
* Master’s or higher.   34
 
Table 5.  Summary Statistics from Pharmaceutical and Semiconductor Industry Samples 
(Units in sales and R&D: thousand dollars) 
  
No. of 
firms  No. of firms reporting  Mean  Standard Deviation 
 Year    employee sales  R&D employee sales  R&D  employee sales  R&D 
 1989  88 85 78 69 5903  895924 85151 13058 1940353 180615 
Pharmaceutical 1990  88 85 81 64 5722  794134 78612 13726 2036458 188652 
Industry 1991  146 137 124 98 4741  884836 95712 12690 2187517 217398 
 1992  151 145 123 109 4694  987210 101187 12374 2404976 237929 
 1993  161 155 132 126 4297  1609557 105501 11764 7440985 250355 
 1994  179 170 149 136 4668  1670350 104193 13395 7693383 255514 
 1995  184 171 150 142 4460  1924112 124575 13263 7897844 323828 
 1996  193 170 158 152 4114  1996128 126510 12652 8085530 355602 
 1997  221 196 193 177 4078  2161856 194237 13980 9156677 797319 




firms  No. of firms reporting  Mean  Standard Deviation 
 Year    employee sales  R&D employee  sales  R&D  employee sales  R&D 
 1989  71 70 71 55 3108  275944 25530 10043 885337 64583 
Semiconductor   1990  67 65 67 52 3273  309869 30203 10102 959953 82405 
Industry 1991  87 86 84 70 3492  410065 28720 13365 1521497 81478 
 1992  93 92 91 79 3244  423890 28546 13226 1698277 94122 
 1993  107 107 103 95 2919  477073 28395 13307 2044170 105515 
 1994  114 112 108 100 2057  590914 33344 6922 2588848 119556 
 1995  131 124 127 115 2050  720290 43822 7156 3103003 151508 
 1996  136 123 131 122 3201  746105 62304 14466 3243984 215290 
 1997  151 141 147 135 3277  1081964 87658 14750 4956544 336703 
 1998  154 125 153 139 3328  1095652 102042 14013 5255021 392838 Table 6.  Inventors with Foreign Experience in US Domestic Patents 
Year  Number of Inventors  Percentage of Inventors by Foreign-Experience Type (%) 
     Current  Foreign  Residents 
 
Current US Residents 
w/ Foreign Experience 
Current US Residents w/o 
Foreign Experience 
  All  Pharma  Semi All  Pharma  Semi All  Pharma  Semi All  Pharma  Semi 
1985  42,368    8.15%    0.99%    90.86%    
1986  44,828     8.30    1.07    90.63    
1987  48,810     8.21    1.13    90.66    
1988  54,947     8.49    1.13    90.37    
1989  59,164  2,143  1,139 8.60 14.47 9.04  1.17  2.01  1.14 90.23  83.53  89.82 
1990  63,812  2,259  1,362 8.02 17.35 7.78  1.22  1.51  1.25 90.76  81.14  90.97 
1991  67,657  3,332  2,791 7.76 19.09 6.02  1.26  1.23  1.22 90.98  79.68  92.76 
1992  73,640  3,876  3,370 7.86 20.38 7.15  1.30  1.21  1.13 90.85  78.41  91.72 
1993  80,428  4,505  4,190 8.06 25.88 7.06  1.21  1.31  1.03 90.73  72.81  91.91 
1994  90,910  5,320  5,739 8.44 26.86  14.76 1.20  0.98  0.94 90.36  72.16  84.30 
1995  104,775  6,629  7,450 8.78 28.87  15.18 1.13  0.87  0.86 90.08  70.25  83.96 
1996  104,829  4,894  7,916 9.19 31.55  13.26 1.07  0.90  0.78 89.75  67.55  85.95 
1997  119,556  6,093  9,993 9.11 29.71  15.31 1.01  0.75  0.80 89.87  69.54  83.89 
Note: Columns 2-4 show the number of unique inventors in all U.S. domestic patents, in pharmaceutical patents, and in semiconductor 
patents, respectively. In columns 8-10, we report the percent of inventors with current addresses in the U.S. who have at least one 
patent in the past 10 years while residing at a foreign address.   1
Table 7.  Variable Definitions and Sample Statistics 
  Definition  Mean (Standard Deviation) 
   Pharmaceutical  Semiconductor 






FRGN_EXP  = 1 if at least one inventor is residing or has resided in the past 
in one of the foreign countries where foreign assignees of cited 
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Table 8 Determinants of Citation to Foreign-Assigned Patents 
 
Dependent variable = logit transform of CITE_FRGN 
 Pharmaceutical  Semiconductor 
  (1) (2) (3) (1) (2) (3) 
        
FRGN_EXP  3.8950 3.3876 4.3832 5.8609 5.5730 6.4162 
  4.95 3.92 3.87 4.18 3.66 3.75 
Log INVENTOR   1.0813  1.1595  -1.1918  -1.1702 
   1.10  1.19    -2.69  -2.64 
Log EMPLOYEE    0.2124 0.1885    0.3871 0.3550 
   0.38  0.34  1.24  1.14 
Log R&D/INV    0.0557 0.0488    0.0658 0.0691 
   0.66  0.59  1.14  1.18 
Log NSIC   -0.2723  -0.4079  1.1469  1.1562 
   -0.38  -0.57    1.57  1.56 
Log MEXP   -6.5845  -6.4702  -6.8640  -6.8410 
   -4.41  -4.40  -2.76  -2.66 
Log FIRMAGE   -1.0956  -1.1361  2.3439  2.3771 
   -1.96  -2.06    2.88  2.83 
        
Observations  1430 1247 1215 4316 4186 4112 
R
2  0.0189 0.1462 0.1539 0.0283 0.1280 0.1306 
Note:  Rows show the estimated coefficient and the t statistic for each regressor.  The result for a constant term is suppressed. Column 
3 shows the results from a regression that omits patents for which an inventor is listed as an inventor on a cited patent.  The t statistic 
is based on the Huber-White sandwich estimator of variance.  
 
 